Answer
Velcade (bortezomib), alone or with pegylated liposomal doxorubicin or dexamethasone, is indicated for adults with progressive multiple myeloma who have received at least one prior therapy and have already undergone or are unsuitable for haematopoietic stem cell transplantation.
Sources for this answer
- Velcade 3.5mg powder for solution for injection (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 37Document updated
Sources checked